The M&A Accretion/Dilution Model Every Founder and Investor Should Run Before Any Deal
- 01EPS Impact Is the Single Most Important Question in Any Acquisition
- 02Most Deal Participants Are Flying Blind
- 03Financial Modeling Fluency Is a Negotiating Advantage
- 04Sensitivity Analysis Is Essential for Board-Level Deal Defense
1. Key Themes
EPS Impact Is the Single Most Important Question in Any Acquisition
The entire framework of M&A analysis reduces to one metric: whether earnings per share rises or falls post-close. The article frames everything else — financing structure, synergies, integration costs, cash/stock mix — as inputs feeding into that verdict.
"The accretion/dilution analysis answers one specific question: after this deal closes, does the acquiring company's earnings per share go up or down?"
Most Deal Participants Are Flying Blind — And That Has Real Costs
The article identifies a widespread knowledge gap in M&A rooms, where participants nod along without genuine understanding, creating dependency on advisors and leaving value on the table.
"Most people never model this themselves. They stay dependent on bankers and advisors to tell them whether a deal is good or bad. That's an expensive way to make decisions worth tens of millions of dollars."
Financial Modeling Fluency Is a Negotiating Advantage
The article frames the ability to run an accretion/dilution model not just as analytical hygiene, but as a direct source of leverage in deal negotiations.
"The ones who have [run this model] are asking the right questions and getting better terms because of it."
Sensitivity Analysis Is Essential for Board-Level Deal Defense
Beyond a single-point EPS verdict, the article highlights the importance of stress-testing assumptions across multiple variables to construct a defensible price range.
"How to use the sensitivity tables to structure a negotiation and present a defensible price range to a board."
2. Contrarian Perspectives
A Dilutive Deal Can Still Be the Right Decision
The consensus assumption is that EPS dilution automatically disqualifies a deal. The article directly challenges this, noting there are at least three scenarios where accepting short-term dilution is the correct strategic trade — though the specific scenarios are gated behind the premium subscription.
"When a dilutive deal is still the right decision — the three scenarios where short-term EPS dilution is the correct trade."
Why this matters: Founders and investors who reflexively reject dilutive deals may be walking away from strategically sound acquisitions. The relevant question is not whether EPS dips, but why and for how long.
The Real Deal Risk Is the Assumptions, Not the Verdict
Most people treat the accretion/dilution output as definitive. The article suggests the more important skill is challenging the inputs that produce it — particularly when someone else is presenting the analysis.
"The questions to ask when someone else presents this analysis to you, so you stop nodding along and start pressure-testing the assumptions that actually drive the verdict."
Why this matters: Bankers and advisors have incentive to close deals. A model can be technically correct but structurally misleading if synergy estimates are inflated or integration costs understated. Independent modeling is a check on motivated reasoning.
3. Companies Identified
The article does not reference any specific companies or case studies. It is primarily a product/resource marketing piece for The VC Corner's premium subscriber library.
4. People Identified
Ruben Dominguez
- Description: Author and founder/operator of The VC Corner newsletter
- Why mentioned: Author of the article; positioned as the subject matter expert on M&A financial modeling for founders and investors
- Quote: (Byline only — no direct quotes attributed to him personally within the article body)
5. Operating Insights
Build the Model Yourself Before Any Deal Conversation
Rather than relying on banker-produced analysis, founders and investors should run their own accretion/dilution model prior to entering negotiations. The key inputs are: offer price, financing structure (cash vs. stock mix), synergies, and integration costs.
"The complexity lives in the variables feeding into it: the offer price, the financing structure, the synergies, the integration costs, the mix of cash and stock."
Use Offer Price Scaling and Sensitivity Tables to Anchor Negotiations
The model described scales across 11 offer price points and includes four two-way sensitivity tables. This kind of range-based analysis — rather than a single-point estimate — gives negotiators a principled basis for price floors and ceilings.
"It handles everything from purchase price and financing structure through to a live EPS verdict, break-even synergy calculation, offer price scaling across 11 price points, and four two-way sensitivity tables stress-testing offer price against cash mix and synergies."
6. Overlooked Insights
Break-Even Synergy Calculation as a Deal Sanity Check
The model includes a break-even synergy calculation — meaning it can tell you exactly how much in synergies is required to make a deal non-dilutive. This is a powerful reverse-engineering tool that is easy to overlook but practically very useful: if the required synergy number is unrealistic given industry benchmarks, the deal math doesn't work at any price.
"It handles everything from purchase price and financing structure through to a live EPS verdict, break-even synergy calculation..."
200+ Sub-$200M Funds Still Actively Deploying
Buried in the resource library description is a reference to a curated database of funds under $200M still actively writing checks — a signal that smaller, more nimble capital sources remain active even in tighter markets, which may be actionable for founders who have been targeting only large-brand VCs.
"200+ funds under $200M still actively deploying, and family offices writing pre-seed checks."